companydata.dkcompanydata.dk

BIOCHEMFUSION HOLDING ApS: Financial statements 2024

CVR: 35398953

Source: annual report 2024, Danish Business Authority

01/01/2024 – 31/12/2024

BIOCHEMFUSION HOLDING ApS (CVR 35398953) has filed annual accounts for 2024. In 2024, the company reported revenue of DKK 30,756 and a net result of DKK 93,935 compared with DKK 12,286 the year before. That is an increase of 24.3% compared with the year before. The profit margin was 305.4%. Equity in the 2024 report amounted to DKK 261,070. The solvency ratio was 95.2%.

Revenue
DKK 30,756
Gross Profit
DKK 24,276
Profit/Loss
DKK 93,935
Equity
DKK 261,070
Total Assets
DKK 274,100
Employees
0

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
202431 t.24 t.94 t.261 t.0
202325 t.16 t.12 t.317 t.0
202221 t.14 t.159 t.455 t.0
202145 t.39 t.178 t.446 t.0
2020-842450 t.567 t.0

Official annual report

View the official annual report directly on the page with a Pro subscription.

Screen every Danish company

Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.

Try company screening

Events in 2024

BIOCHEMFUSION HOLDING ApS: The 2023 annual report is outMay 30, 2024

BIOCHEMFUSION HOLDING ApS has published its annual report for 2023. Revenue came to DKK 24,747, and the net result was DKK 12,286.

About BIOCHEMFUSION HOLDING ApS

BIOCHEMFUSION HOLDING ApS is a Danish company of the type Anpartsselskab based in Ølsted, founded in 2013. The company is registered under the industry Finansielle holdingselskaber. The management consists of Jan Holst Jensen. The company is owned by JAN HOLST HOLDING ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported revenue of DKK 28,888 and a net result of DKK 16,110 compared with DKK 93,935 the year before. Equity in the 2025 report amounted to DKK 226,586.

Source: annual report 2025, Danish Business Authority